We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

2 hedge funds and large institutions have $3.1M invested in Heron Therapeutics in 2013 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

4,213% more capital invested

Capital invested by funds: $72K → $3.1M (+$3.03M)

100% more funds holding

Funds holding: 1 → 2 (+1)

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VM
VHCP Management
New York
+$3.04M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
VM
1
VHCP Management
New York
$3.04M +$3.04M +453,385 New
EEG
2
E.E. Geduld
$67K – – –

HRTX Hedge Fund Activity: Q3 2013 in Review

2 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q3 2013, worth a combined $3.1M — up 4,213% from $72K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new HRTX positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was VHCP Management, opening a new position worth an estimated $3.04M.

  • 2 institutional investors held Heron Therapeutics (HRTX) as of Q3 2013, up from 1 in Q2 2013.
  • Funds reported $3.1M of Heron Therapeutics stock for Q3 2013, up 4,213% quarter-over-quarter.
  • 1 fund opened new Heron Therapeutics positions in Q3 2013 and 0 closed out, a net change of +1 holder.
  • The largest Heron Therapeutics buyer in Q3 2013 was VHCP Management, an estimated $3.04M added.

Based on aggregated 13F filings for Q3 2013.